Report Overview
Report Summary
Eternity Insights has published a new study on Global Risperidone Market focusing on key segments as by Type (Tablet, Capsule, Solution, Others), by Application (Schizophrenia, Bipolar disorder, Autism, Other uses), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Risperidone Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Risperidone Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Risperidone Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Risperidone Market Segmentation:
Risperidone Market, By Type
- Tablet
- Capsule
- Solution
- Others
Risperidone Market, By Application
- Schizophrenia
- Bipolar disorder
- Autism
- Other uses
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Risperidone market in terms of demand generation. The Risperidone market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Risperidone market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Risperidone Market Taxonomy:
To learn more about this report
Global Risperidone Market Competitive Landscape
The global Risperidone market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Janssen Pharmaceutica
- Teva
- Sun Pharmaceutical
- Aurobindo
- Cipla
- Invent Farma Group
- Medichem
- Interquim
- IPCA
- RPG
- Sharon
- Torrent Pharmaceuticals
- Temad
- Wuxi Jida
- Changzhou Siyao Pharmaceuticals
- Ningbo Team Pharm
- Zhejiang Huahai Pharmaceutical
- TIPR
- Qilu Pharmaceutical
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Tablet, Capsule, Solution, Others |
| By Application Outlook |
Schizophrenia, Bipolar disorder, Autism, Other uses |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Janssen Pharmaceutica, Teva, Sun Pharmaceutical, Aurobindo, Cipla, Invent Farma Group, Medichem, Interquim, IPCA, RPG, Sharon, Torrent Pharmaceuticals, Temad, Wuxi Jida, Changzhou Siyao Pharmaceuticals, Ningbo Team Pharm, Zhejiang Huahai Pharmaceutical, TIPR, Qilu Pharmaceutical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table Of Contents
Table of Contents
1 Risperidone Market Overview
1.1 Risperidone Product Overview
1.2 Risperidone Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Solution
1.2.4 Others
1.3 Global Risperidone Market Size by Type
1.3.1 Global Risperidone Sales and Growth by Type
1.3.2 Global Risperidone Sales and Market Share by Type (2013-2018)
1.3.3 Global Risperidone Revenue and Market Share by Type (2013-2018)
1.3.4 Global Risperidone Price by Type (2013-2018)
2 Global Risperidone Market Competition by Company
2.1 Global Risperidone Sales and Market Share by Company (2013-2018)
2.2 Global Risperidone Revenue and Share by Company (2013-2018)
2.3 Global Risperidone Price by Company (2013-2018)
2.4 Global Top Players Risperidone Manufacturing Base Distribution, Sales Area, Product Types
2.5 Risperidone Market Competitive Situation and Trends
2.5.1 Risperidone Market Concentration Rate
2.5.2 Global Risperidone Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Risperidone Company Profiles and Sales Data
3.1 Janssen Pharmaceutica
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Risperidone Product Category, Application and Specification
3.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Teva
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Risperidone Product Category, Application and Specification
3.2.3 Teva Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Sun Pharmaceutical
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Risperidone Product Category, Application and Specification
3.3.3 Sun Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Aurobindo
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Risperidone Product Category, Application and Specification
3.4.3 Aurobindo Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Cipla
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Risperidone Product Category, Application and Specification
3.5.3 Cipla Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Invent Farma Group
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Risperidone Product Category, Application and Specification
3.6.3 Invent Farma Group Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Medichem
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Risperidone Product Category, Application and Specification
3.7.3 Medichem Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Interquim
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Risperidone Product Category, Application and Specification
3.8.3 Interquim Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 IPCA
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Risperidone Product Category, Application and Specification
3.9.3 IPCA Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 RPG
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Risperidone Product Category, Application and Specification
3.10.3 RPG Risperidone Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
3.11 Sharon
3.12 Torrent Pharmaceuticals
3.13 Temad
3.14 Wuxi Jida
3.15 Changzhou Siyao Pharmaceuticals
3.16 Ningbo Team Pharm
3.17 Zhejiang Huahai Pharmaceutical
3.18 TIPR
3.19 Qilu Pharmaceutical
4 Risperidone Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Risperidone Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Risperidone Sales and Revenue by Regions
4.2.1 Global Risperidone Sales and Market Share by Regions (2013-2018)
4.2.2 Global Risperidone Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Risperidone Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Risperidone Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Risperidone Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Risperidone Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Risperidone Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Risperidone Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Risperidone Application/End Users
5.1 Risperidone Segment by Application
5.1.1 Schizophrenia
5.1.2 Bipolar disorder
5.1.3 Autism
5.1.4 Other uses
5.2 Global Risperidone Product Segment by Application
5.2.1 Global Risperidone Sales by Application
5.2.2 Global Risperidone Sales and Market Share by Application (2013-2018)
6 Global Risperidone Market Forecast
6.1 Global Risperidone Sales, Revenue Forecast (2018-2025)
6.1.1 Global Risperidone Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Risperidone Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Risperidone Forecast by Regions
6.2.1 North America Risperidone Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Risperidone Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Risperidone Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Risperidone Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Risperidone Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Risperidone Forecast by Type
6.3.1 Global Risperidone Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Tablet Gowth Forecast
6.3.3 Capsule Gowth Forecast
6.4 Risperidone Forecast by Application
6.4.1 Global Risperidone Sales Forecast by Application (2018-2025)
6.4.2 Global Risperidone Forecast in Schizophrenia
6.4.3 Global Risperidone Forecast in Bipolar disorder
7 Risperidone Upstream Raw Materials
7.1 Risperidone Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Risperidone Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer